AmphiStar has been awarded a new €2.5 million funding by SPRIND, Germany’s Federal Agency for Disruptive Innovation, to accelerate continuous manufacturing of its sustainable microbial biosurfactants.
The highly innovative SPRIND program identifies and supports only the most transformative technologies in Europe. The SPRIND Circular Biomanufacturing challenge consists of 3 stages. In stage 2, six ambitious teams conducted techno-economic, and life cycle assessments, all while advancing the commercialisation of the biochemicals they are targeting. In stage 3, five teams will continue the challenge to produce three different products from waste in a 180 day continuous production.
The SPRIND funding enables AmphiStar to advance its continuous fermentation technology and accelerate the commercialisation of new biosurfactant molecules from its expanding library, all of which are produced through the microbial upcycling of bio-based waste feedstocks into sustainable, market-ready ingredients.
This renewed SPRIND support demonstrates strong confidence in AmphiStar’s vision and technological potential”, said Dr. Sophie Roelants, COO and Co-Founder of AmphiStar. The funding will help us to optimise our continuous fermentation process further and unlock the next phase of commercialisation, bringing truly sustainable, waste-based biosurfactants closer to mainstream markets.”
It is an honor to be recognized as one of the final five participants in Stage 3 of the SPRIND Challenge, following the challenging and thorough assessment conducted by the expert jury”, said Pierre-Franck Valentin, CEO of AmphiStar. This funding strengthens our ability to deliver high-performance, circular ingredients that reduce environmental impact and accelerate the transition to a low-carbon, sustainable economy.”
AmphiStar’s biosurfactant platform combines synthetic biology and microbial fermentation to create high-performance ingredients from upcycled bio-based waste and side streams. Free from fossil and palm feedstocks, its biosurfactants deliver a cleaner, scalable alternative to conventional surfactants.
The company’s recent partnerships with Kensing in North America and Caldic in Europe underline the growing global demand for sustainable, waste-based solutions and mark key steps toward market readiness and large-scale adoption of circular biosurfactants.
